Work

Unlocking PARP inhibitor efficacy for HRD-negative cancers using the alphalex tumor targeting platform inhibitor efficacy for HRD-negative cancers using the alphalex tumor targeting platform.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.e14664

Authors: Ranjit Bindra, Ranjini K Sundaram, Robert J Aiello, Dan Marshall, Patricia Bourassa, Johanna Csengery, Qing Zhang, Brett Robinson, Lori lopresti-Morrow, Jane Bechtold, Laurie Tylaska, Tim Paradis, Vishwas Paralkar, Per Hellsund, Peter Glazer

Institution: Yale University

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2946928256

Cites:

Cited by: 2

Related to: 10